Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metmost GV 1mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Biomax Biotechnics Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Metmost GV 1mg/500mg/0.3mg Tablet

Diabetic patients using the anti-diabetic medication, Metmost GV (1mg/500mg/0.3mg), a combination drug, should adhere to the prescribed dosage and timing. This medication helps regulate blood glucose in adult type 2 diabetics. Administer this tablet with food, consistently at the same time daily, for optimal efficacy. Dosage adjustments are determined by your physician based on your blood sugar readings. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Commonly reported is hypoglycemia (low blood sugar). Learn to recognize symptoms—sweating, dizziness, headache, trembling—and possess readily available glucose (e.g., sugary foods, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions necessitate informing your doctor before starting this treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Regular blood glucose monitoring, alongside periodic blood tests to assess blood cell counts and liver function, are vital components of treatment.

Uses of Metmost GV 1mg/500mg/0.3mg Tablet

Managing Type 2 Diabetes

Major Benefits of Metmost GV 1mg/500mg/0.3mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Metmost GV 1mg/500mg/0.3mg Tablet should be administered on an empty stomach.

Common Side effects of Metmost GV 1mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Metmost GV 1mg/500mg/0.3mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metmost GV 1mg/500mg/0.3mg tablets on an empty stomach.

How Metmost GV 1mg/500mg/0.3mg Tablet works:

Each Metmost GV tablet (1mg/500mg/0.3mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metmost GV 1mg/500mg/0.3mg tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metmost GV 1mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Metmost GV 1mg/500mg/0.3mg Tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Metmost GV 1mg/500mg/0.3mg Tablets are likely unsafe for individuals with kidney impairment and should be eschewed. Medical advice is recommended. Furthermore, their use is contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Individuals with liver impairment should use Metmost GV 1mg/500mg/0.3mg Tablets cautiously, as dose modification may be necessary. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a reduced dosage; however, the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metmost GV 1mg/500mg/0.3mg Tablet :

Should you forget a Metmost GV 1mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metmost GV 1mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metmost GV 1mg/500mg/0.3mg Tablet

Metmost GV 1mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Metmost GV 1mg/500mg/0.3mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infections.
Metmost GV 1mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any ingredient. Avoid use in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Metmost GV 1mg/500mg/0.3mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Metmost GV 1mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), resulting in symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, like glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metmost GV 1mg/500mg/0.3m...
97
MRP 112
13% off